89 related articles for article (PubMed ID: 19907721)
1. Increased plasma endothelin level as an endothelial marker of cardiovascular risk in patients with active acromegaly: a comparison with plasma homocysteine.
Kirilov G; Zacharieva S; Alexandrov AS; Lozanov V; Mitev V
Methods Find Exp Clin Pharmacol; 2009 Sep; 31(7):457-61. PubMed ID: 19907721
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine levels in acromegaly patients.
Hekimsoy Z; Ozmen B; Ulusoy S
Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
[TBL] [Abstract][Full Text] [Related]
3. Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement.
Lewandowski KC; Murray RD; Drzewoski J; O'Callaghan CJ; Czupryniak L; Hillhouse EW; Shalet SM; Randeva HS
Mol Genet Metab; 2003 Nov; 80(3):330-7. PubMed ID: 14680980
[TBL] [Abstract][Full Text] [Related]
4. Alterations in biomarkers of cardiovascular disease (CVD) in active acromegaly.
Boero L; Manavela M; Gómez Rosso L; Insua C; Berardi V; Fornari MC; Brites F
Clin Endocrinol (Oxf); 2009 Jan; 70(1):88-95. PubMed ID: 19128365
[TBL] [Abstract][Full Text] [Related]
5. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
Maturana MA; Breda V; Lhullier F; Spritzer PM
Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
[TBL] [Abstract][Full Text] [Related]
6. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
[TBL] [Abstract][Full Text] [Related]
7. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
Woolf K; Manore MM
J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
[TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction in patients with noncomplicated and complicated hypertension.
Goch A; Banach M; Mikhailidis DP; Rysz J; Goch JH
Clin Exp Hypertens; 2009 Feb; 31(1):20-30. PubMed ID: 19172456
[TBL] [Abstract][Full Text] [Related]
10. Reduced serum homocysteine levels in type 2 diabetes.
Mazza A; Bossone E; Mazza F; Distante A
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):118-24. PubMed ID: 15871860
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
12. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
[TBL] [Abstract][Full Text] [Related]
13. Raised plasma endothelin-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis.
Mangiafico RA; Malatino LS; Santonocito M; Spada RS; Polizzi G; Tamburino G
Int Angiol; 1996 Sep; 15(3):240-4. PubMed ID: 8971583
[TBL] [Abstract][Full Text] [Related]
14. Study of homocysteine concentration in coronary heart disease patients and comparison of two determination methods.
Doncheva N; Penkov A; Velcheva A; Boev M; Popov B; Niagolov Y
Ann Nutr Metab; 2007; 51(1):82-7. PubMed ID: 17356259
[TBL] [Abstract][Full Text] [Related]
15. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
Boufidou AI; Makedou AD; Adamidis DN; Karvounis HI; Gourassas JT; Kesidis HT; Makedou KG; Papadopoulos CE; Parharidis GE; Louridas GE
Curr Med Res Opin; 2004; 20(2):175-80. PubMed ID: 15006011
[TBL] [Abstract][Full Text] [Related]
16. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
17. Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians.
Pitla S; Nagalla B
Ann Nutr Metab; 2009; 54(1):1-6. PubMed ID: 19194102
[TBL] [Abstract][Full Text] [Related]
18. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
19. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
[TBL] [Abstract][Full Text] [Related]
20. Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly.
Jaskula M; Wasko R; Komarowska H; Dziubandowska A; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):245-55. PubMed ID: 19675514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
